Vous avez sélectionné la vue dans Anglais
Descripteur en français: | Récepteur activateur du facteur nucléaire Kappa B | ||||||
Descripteur en anglais: | Receptor Activator of Nuclear Factor-kappa B | ||||||
Descripteur en espagnol: |
Receptor Activador del Factor Nuclear kappa-B
| ||||||
Descripteur en portugais: | Receptor Ativador de Fator Nuclear kappa-B | ||||||
Synonymes: |
Activator, NF-KappaB Receptor Antigen, CD265 CD265 Antigen NF Kappa B Receptor Activator NF KappaB Receptor Activator NF-Kappa B Receptor Activator NF-KappaB Receptor Activator RANK Protein Receptor Activator of NF kappa B Receptor Activator of NF kappaB Receptor Activator of NF-kappa B Receptor Activator of NF-kappaB Receptor Activator of Nuclear Factor kappa B Receptor Activator of Nuclear Factor kappaB Receptor Activator of Nuclear Factor-kappaB Receptor Activator, NF-KappaB Receptors, Tumor Necrosis Factor, Member 11a TNFRSF11A Protein TRANCE R TRANCE Receptor TRANCE-R Tumor Necrosis Factor Receptor Superfamily, Member 11a |
||||||
Code(s) d'arborescence: |
D12.776.543.750.705.852.760.345 |
||||||
Identificateur unique RDF: | https://id.nlm.nih.gov/mesh/D053246 | ||||||
Note d'application: | A tumor necrosis factor receptor family member that is specific for RANK LIGAND and plays a role in bone homeostasis by regulating osteoclastogenesis. It is also expressed on DENDRITIC CELLS where it plays a role in regulating dendritic cell survival. Signaling by the activated receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS. |
||||||
Qualificatifs autorisés: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
Note publique MeSH: | 2007; for RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 11A see GLYCOPROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; & RECEPTORS, CYTOPLASMIC AND NUCLEAR 1997-2005 |
||||||
Note historique: | 2007(1997) |
||||||
Identifiant DeCS: | 52389 | ||||||
ID du Descripteur: | D053246 | ||||||
Documents indexés dans la Biblioteque Virtuelle de Santé (BVS): | Cliquez ici pour accéder aux documents VHL | ||||||
Date d'établissement: | 01/01/2007 | ||||||
Date d'entrée: | 05/07/2006 | ||||||
Date de révision: | 24/05/2017 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
Receptor Activator of Nuclear Factor-kappa B
- Concept préféré
Concept UI |
M0371270 |
Note d'application | A tumor necrosis factor receptor family member that is specific for RANK LIGAND and plays a role in bone homeostasis by regulating osteoclastogenesis. It is also expressed on DENDRITIC CELLS where it plays a role in regulating dendritic cell survival. Signaling by the activated receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS. |
Terme préféré | Receptor Activator of Nuclear Factor-kappa B |
Synonymes |
Activator, NF-KappaB Receptor Antigen, CD265 CD265 Antigen NF Kappa B Receptor Activator NF KappaB Receptor Activator NF-Kappa B Receptor Activator NF-KappaB Receptor Activator RANK Protein Receptor Activator of NF kappa B Receptor Activator of NF kappaB Receptor Activator of NF-kappa B Receptor Activator of NF-kappaB Receptor Activator of Nuclear Factor kappa B Receptor Activator of Nuclear Factor kappaB Receptor Activator of Nuclear Factor-kappaB Receptor Activator, NF-KappaB Receptors, Tumor Necrosis Factor, Member 11a TNFRSF11A Protein TRANCE R TRANCE Receptor TRANCE-R Tumor Necrosis Factor Receptor Superfamily, Member 11a |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey